These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Salvage peptide receptor radionuclide therapy with [ van der Zwan WA; Brabander T; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; Krenning EP; de Herder WW Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):704-717. PubMed ID: 30267116 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of peptide receptor radionuclide therapy with Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhang J; Zhu Z; Chen X Theranostics; 2022; 12(15):6437-6445. PubMed ID: 36185603 [No Abstract] [Full Text] [Related]
19. Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment. Hamiditabar M; Ali M; Roys J; Wolin EM; OʼDorisio TM; Ranganathan D; Tworowska I; Strosberg JR; Delpassand ES Clin Nucl Med; 2017 Jun; 42(6):436-443. PubMed ID: 28263217 [TBL] [Abstract][Full Text] [Related]
20. Visual and whole-body quantitative analyses of Hotta M; Sonni I; Thin P; Nguyen K; Gardner L; Ciuca L; Hayrapetian A; Lewis M; Lubin D; Allen-Auerbach M Ann Nucl Med; 2024 Apr; 38(4):296-304. PubMed ID: 38252228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]